Foghorn Therapeutics Inc.
3 clinical trials · Sponsor
◉ Watch Foghorn Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors (NCT04965753) | Foghorn Therapeutics Inc. | 2021-08-17 |
| FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies (NCT04891757) | Foghorn Therapeutics Inc. | 2021-06-14 |
| FHD-286 in Subjects With Metastatic Uveal Melanoma (NCT04879017) | Foghorn Therapeutics Inc. | 2021-05-11 |
Track Foghorn Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.